Genmab to Submit sBLA to FDA for Epcoritamab in Combination with Rituximab and Lenalidomide in Relapsed or Refractory Follicular Lymphoma Genmab A/S (Nasdaq: GMAB) has announced its plan to submit…
InnoCare’s Next-Generation TRK Inhibitor Zurletrectinib Granted Priority Review by China’s NMPA for NTRK Fusion-Positive Tumors A prominent biopharmaceutical company dedicated to the development of innovative therapies for cancer and autoimmune…
Adicet Bio Issues Equity Awards to New Employees Pursuant to Nasdaq Inducement Rule 5635(c)(4) Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company advancing gamma delta T cell therapies for cancer,…
Global Lipid-Based Pharma Excipients Market Set to Reach $1.32 Billion by 2030, Driven by Innovation and Rising Demand for Advanced Drug Delivery Systems The newly released report, “Lipid-Based Pharma Excipients…
Landmark Study Demonstrates Significant 4-Year Survival Benefit in Heart Transplant Patients Using Paragonix SherpaPak System Paragonix Technologies, a pioneer in advanced organ transplant preservation and organ procurement services, has announced…
U.S. Cryogenic Biobanking Services Market Forecast 2025–2030: Innovation Driven by Cord Blood Conservation and Personalized Medicine Industry Outlook & Forecast 2025-2030” from ResearchAndMarkets.com presents a comprehensive analysis of one of…
In March 2022, Nick De Graw, a 20-year-old sophomore majoring in mechanical engineering at the University of California, Irvine, noticed some unusual symptoms that led him to believe he might…
AbCellera Presents Promising Preclinical Data Demonstrating Efficacy of PSMA x CD3 T-Cell Engagers at AACR 2025 AbCellera Biologics Inc. (Nasdaq: ABCL), a leading technology company specializing in the discovery and…
Innate Pharma Presents Compelling Preclinical Data on Novel ADC Candidate IPH4502 Targeting Nectin-4 at AACR 2025 Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA), a biotechnology company specializing in the…
USPTO Invalidates Pharmacyclics Patent Challenged by BeiGene in BRUKINSA Dispute In a significant development in the ongoing intellectual property battle between two major players in the oncology therapeutics market, BeiGene,…
Xencor Reports Positive Interim Data From First-in-Human Study of XmAb942, Plans Phase 2b Trial for Inflammatory Bowel Disease Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company specializing in the development…
QIAGEN Expands Digital PCR Portfolio With Advanced Lentivirus Solutions to Elevate Quality Control in Cell and Gene Therapy Manufacturing QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA), a global leader in…